BIOMARKER STRATEGIES
Live / Registered — Registered and renewed (as of 09 Aug 2017)
What this means for you
Registered since 07 Aug 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Aug 2017).
Record
- Serial number
- 78874705
- Registration number
- 3274871
- Mark type
- Design + words
- Filed
- 02 May 2006
- Published for opposition
- 22 May 2007
- Registered
- 07 Aug 2007
- Next maintenance due
- 07 Aug 2017
Goods and services
- Class 042 — Scientific and technological services: Performing scientific research or providing scientific research services to identify the most informative, effective and efficient panels of biomarkers to aid in the new drug development and clinical trial process; Providing biomarker-related technical consulting, scientific research, assay development, and testing services to support new drug development and clinical trials; Conducting scientific research related to the discovery and identification of novel biomarkers of interest; Providing scientific research services to pharmaceutical companies, Contract Research Organizations (CROs), and diagnostic testing companies to support the integration of molecular biomarker assays into clinical trials and new drug/product codevelopment efforts; Developing biomarker molecular assays, including multiplexed assays, to assist with pre-clinical drug development and pharmacokinetic and pharmacodynamic scientific studies; and to assist with clinical trials to evaluate clinical trial safety, efficacy, toxicology, and dosing; Providing technical consulting and scientific research services to identify and use a full range of germline and tissue-specific DNA, RNA and protein- based molecular biomarkers, including-- single nucleotide polymorphisms (SNPs), DNA point mutations, deletions, translocations, inversions and amplifications, DNA methylation, microbial DNA detection, gene expression analysis (mRNA), protein expression and modification (phosphorylation, acetylation, methylation), lipid analysis, carbohydrate analysis, and whole cell analysis
Owner
- Biomarker Strategies, LLC, Rockville, MD, US
- Biomarker Strategies, LLC, Baltimore, MD, US
- Biomarker Strategies, LLC, Baltimore, MD, US
Prosecution history
- 13 Jun 2024 — WITHDRAWAL OF ATTORNEY GRANTED
- 13 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 07 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Feb 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Feb 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Sept 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Sept 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Aug 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Aug 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Aug 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Aug 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Jun 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2017 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Jun 2017 — TEAS SECTION 8 & 9 RECEIVED
- 07 Aug 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED